LimFlow, Inc.: Clinical Trials

4 trials sponsored by LimFlow, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting, 1 unknown. 3 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 1, Recruiting 1, Unknown 1

Follow LimFlow, Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
LimFlow Stent Graft System - Critical Limb Ischemia, Chronic Limb-Threatening Ischemia
Not applicableRecruitingLimFlow, Inc.1002022-12-222026-04-16
Natural Progression of High-Risk Chronic Limb-Threatening Ischemia: The CLariTI Study
Critical Limb Ischemia, Peripheral Artery Disease
CompletedLimFlow, Inc.1922020-02-242024-11-20
PROMISE II: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
LimFlow System - Critical Limb Ischemia, Critical Lower Limb Ischemia
Not applicableUnknownLimFlow, Inc.1052019-12-062024-02-28
PROMISE I Early Feasibility Trial of the LimFlow Stent Graft System
LimFlow System - Critical Limb Ischemia, Chronic Limb-Threatening Ischemia
Not applicableCompletedLimFlow, Inc.322017-07-052024-05-21

Conditions studied

Chronic Limb-Threatening Ischemia (4)  ·  Peripheral Arterial Disease (3)  ·  Arterial Occlusive Diseases (1)  ·  Peripheral Vascular Diseases (1)  ·  Vascular Diseases (1)

Countries

United States (4)  ·  Puerto Rico (2)

Top investigators

Daniel Clair, MD (2)  ·  Mehdi Shishehbor (2)  ·  Jihad Mustapha, MD (1)

Results publications

PMID 30819976, PMID 34019990, PMID 36988592